AbbVie has announced the availability of ELAHERE® (mirvetuximab soravtansine) in Singapore for the treatment of plat...
AbbVie has received European Commission approval for AQUIPTA, or atogepant, as an acute treatment for migraine in adults...
AbbVie has announced a $1.4 billion investment to build a 185-acre pharmaceutical manufacturing campus in Durham, N...
Santen Pharmaceutical Co. has announced that Santen China has entered into a distribution and promotion agreement with A...
China-based Haisco Pharmaceutical Group has entered into an exclusive licensing agreement with AbbVie, a global biopharm...
AbbVie has announced the start of construction of a $70 million expansion at its AbbVie Bioresearch Center (ABC) in...
To accelerate clinical trial activation and execution, enhance research quality, and strengthen international competitiv...
The China Medical University Hospital Clinical Trial Center (CMUH-CTC) is committed to enhancing clinical trials within ...
National Taiwan University Hospital (NTUH) and AbbVie Biopharmaceuticals GmbH Taiwan Branch (AbbVie) have signed a coope...
US-based firm AbbVie and FutureGen Biopharmaceutical (Beijing) have announced a license agreement to develop FG-M701, a ...
By Hithaishi Bhaskar AbbVie expanded its Singapore manufacturing facility on 25th Jan, strengthening its manufacturing ...
Japanese firm Sosei Group Corporation and US-based AbbVie, a research-based global biopharmaceutical company, have enter...
Rheumatoid arthritis (RA) treatment landscape in Australia is well established with several novel disease-modifying anti...
The hepatitis C virus (HCV) therapeutics market in Japan is highly competitive with stiff competition between Gilead and...
China based Harbour BioMed and Utrecht University in the Netherlands have announced that they licensed to American firm ...
US-based AbbVie and Genmab announced on 10 June 2020 that they had formed the partnership that will focus on b...
US based company AbbVie, Harbour BioMed (HBM) with operations in US and China, Utrecht University (UU) in Europe and Era...
AbbVie, a research-based global biopharmaceutical company, has announced that the U.S. Food and Drug Administratio...
AbbVie and Allergan have announced that the companies have entered into a definitive transaction agreement und...
The NHS will find and cure tens of thousands more people with hepatitis C as part of a ground-breaking deal that could h...
AbbVie , a research-based global biopharmaceutical company has announced that the U.S. Food and Drug Administration (FDA...
AbbVie, a research-based global biopharmaceutical company, has announced that the Japanese Ministry of Health, Labour an...
AbbVie, biopharmaceutical company and Voyager Therapeutics, a clinical-stage gene therapy company focused on developing ...
AbbVie, a research-based global biopharmaceutical company has announced an update on the Phase 3 RESOLVE trial (PCYC-113...
Biopharma company, AbbVie and Biotech company, Tizona Therapeutics has announced that they have entered into a global, s...
